{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T19:15:20Z","timestamp":1789067720393,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Technology Innovation Guidance Program of Science and Technology, Department of Hunan Province","award":["2021SK51710"],"award-info":[{"award-number":["2021SK51710"]}]},{"name":"Major Guiding Project of Hunan Health Committee","award":["20201912"],"award-info":[{"award-number":["20201912"]}]},{"name":"Shenzhen Science and Technology Program","award":["JCYJ20220530144412028"],"award-info":[{"award-number":["JCYJ20220530144412028"]}]},{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["2021A1515111207"],"award-info":[{"award-number":["2021A1515111207"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["NSFC82202891"],"award-info":[{"award-number":["NSFC82202891"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to clarify the prognostic significance of intracranial pressure (ICP) monitoring in patients with aneurysmal subarachnoid hemorrhage (aSAH) who underwent surgical treatment. Specifically, we analyzed clinical demographic data and ICP-related parameters (e.g., optimal cerebral perfusion pressure [CPPopt], \u0394CPP) to identify key prognostic indicators, with the ultimate goal of providing evidence to guide and optimize postoperative management strategies for this patient population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Retrospective analysis of prospectively collected data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Neurosciences critical care unit of a university hospital.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients<\/jats:title>\n                    <jats:p>A prospective cohort of 15 aSAH patients undergoing multiparameter monitoring (April 2024\u2013January 2025) and a retrospective cohort of 45 surgically treated aSAH patients (2022\u20132024) were included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>None.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and main results<\/jats:title>\n                    <jats:p>Demographic data, ICP monitoring results, and Glasgow Outcome Scale (GOS) scores were collected from all patients at one month postoperatively. The absolute difference between the optimal cerebral perfusion pressure (CPPopt) and the 15-min mean cerebral perfusion pressure (CPP) was defined as \u0394CPP.\u200b<\/jats:p>\n                    <jats:p>Patients were stratified into two groups based on their GOS scores: the favorable prognosis group (GOS 4\u20135) and the poor prognosis group (GOS 1\u20133). Subsequently, statistical analysis was performed to explore the associations between prognostic outcomes and both demographic data (e.g., gender, age, surgical approaches) and monitoring parameters (e.g., pressure reactivity index [PRx], pressure reactivity slope [RAP], ICP, \u0394CPP).<\/jats:p>\n                    <jats:p>A retrospective cohort of 52 patients with aSAH \u2014 treated at the Second Hospital of the University of South China between 2022 and 2024 \u2014 was matched with a prospective cohort at a 1:3 ratio using propensity score matching (conducted via R software). After matching, 45 patients from the prospective cohort were retained as controls. Baseline characteristics were well-balanced between the retrospective (test) group and the prospective (control) group, and the distributions of prognostic outcomes were compared between the two groups.<\/jats:p>\n                    <jats:p>Elevated initial ICP was a strong predictor of poor prognosis (41.33\u2009\u00b1\u200910.23 vs. 25.89\u2009\u00b1\u200910.42\u00a0mm Hg, p\u2009=\u20090.014). In patients with ICP\u2009\u2265\u200925\u00a0mm Hg, decompressive craniectomy (DC) was associated with a trend toward improved outcomes (Relative Risk [RR] \u22484.8, p\u2009=\u20090.08).\u200b<\/jats:p>\n                    <jats:p>The poor-outcome group exhibited a greater mean \u0394CPP compared with the favorable-outcome group (12.88 vs. 10.61, p\u2009=\u20090.033). Hypoperfusion (i.e., cerebral perfusion pressure [CPP]\u2009&lt;\u2009optimal CPP [CPPopt]) was significantly associated with adverse outcomes (p\u2009=\u20090.038). In contrast, hyperperfusion (i.e., CPP\u2009&gt;\u2009CPPopt) was not significantly associated with harm (p\u2009=\u20090.084).\u200b<\/jats:p>\n                    <jats:p>Furthermore, patients who underwent ICP monitoring had a higher favorable prognosis rate than those without monitoring (60% vs. 31.1%, p\u2009=\u20090.046).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>First, in the clinical management of aSAH patients, ICP monitoring plays a pivotal role: it not only facilitates surgical decision-making (e.g., selection of decompressive craniectomy) but also optimizes postoperative hemodynamic management strategies tailored to individual patients.\u200b<\/jats:p>\n                    <jats:p>Second, two key factors were identified to predict poor prognosis in aSAH patients: one is the deviation from postoperative CPPopt, among which hypoperfusion is a particularly impactful subtype; the other is elevated initial ICP.\u200b<\/jats:p>\n                    <jats:p>Furthermore, this study confirmed that management guided by multiparameter monitoring significantly improves short-term clinical outcomes in aSAH patients, providing practical evidence for the optimized clinical management of this patient population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10143-025-04016-9","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:56:01Z","timestamp":1766192161000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of intracranial pressure and related parameters on prognosis in patients undergoing surgery for ruptured intracranial aneurysms"],"prefix":"10.1007","volume":"49","author":[{"given":"Tao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyifan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanding","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghua","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajie","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenzhuo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhoucheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghong","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,20]]},"reference":[{"key":"4016_CR1","doi-asserted-by":"publisher","unstructured":"Hoh BL, Ko NU, Amin-Hanjani S, et al: 2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage: A Guideline From the American Heart Association\/American Stroke Association [Internet]. Stroke 2023; 54[cited 2024 Feb 19]: https:\/\/doi.org\/10.1161\/STR.0000000000000436","DOI":"10.1161\/STR.0000000000000436"},{"key":"4016_CR2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s12028-023-01752-y","volume":"39","author":"A Addis","year":"2023","unstructured":"Addis A, Baggiani M, Citerio G (2023) Intracranial pressure monitoring and management in aneurysmal subarachnoid hemorrhage. Neurocrit Care 39:59\u201369","journal-title":"Neurocrit Care"},{"key":"4016_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22095050","volume":"22","author":"L-T Kuo","year":"2021","unstructured":"Kuo L-T, Huang AP-H (2021) The pathogenesis of hydrocephalus following aneurysmal subarachnoid hemorrhage. Int J Mol Sci 22:5050","journal-title":"Int J Mol Sci"},{"key":"4016_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1227\/NEU.0000000000001432","volume":"80","author":"N Carney","year":"2017","unstructured":"Carney N, Totten AM, O\u2019Reilly C et al (2017) Guidelines for the Management of Severe Traumatic Brain Injury. Fourth Edition Neurosurgery 80:6\u201315","journal-title":"Fourth Edition Neurosurgery"},{"key":"4016_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.wnsx.2023.100160","volume":"18","author":"T Svedung Wettervik","year":"2023","unstructured":"Svedung Wettervik T, Lew\u00e9n A, Enblad P (2023) Fine tuning of neurointensive care in aneurysmal subarachnoid hemorrhage: from one-size-fits-all towards individualized care. World Neurosurgery: X 18:100160","journal-title":"World Neurosurgery: X"},{"key":"4016_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/00006123-199707000-00005","volume":"41","author":"M Czosnyka","year":"1997","unstructured":"Czosnyka M, Smielewski P, Kirkpatrick P et al (1997) Continuous assessment of the cerebral vasomotor reactivity in head injury. Neurosurgery 41:11\u201319","journal-title":"Neurosurgery"},{"key":"4016_CR7","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1097\/00003246-200204000-00002","volume":"30","author":"LA Steiner","year":"2002","unstructured":"Steiner LA, Czosnyka M, Piechnik SK et al (2002) Continuous monitoring of cerebrovascular pressure reactivity allows determination of optimal cerebral perfusion pressure in patients with traumatic brain injury. Crit Care Med 30:733\u2013738","journal-title":"Crit Care Med"},{"key":"4016_CR8","doi-asserted-by":"publisher","DOI":"10.3171\/foc.2007.22.5.11","volume":"22","author":"M Czosnyka","year":"2007","unstructured":"Czosnyka M, Lavinio A, Pickard JD (2007) Intracranial pressure: more than a number. Neurosurg Focus 22:E10","journal-title":"Neurosurg Focus"},{"key":"4016_CR9","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1089\/neu.2018.6157","volume":"36","author":"TS Wettervik","year":"2019","unstructured":"Wettervik TS, Howells T, Enblad P et al (2019) Temporal neurophysiological dynamics in traumatic brain injury \u2013 the role of pressure reactivity and optimal cerebral perfusion pressure for predicting outcome. J Neurotrauma 36:1818\u20131827","journal-title":"J Neurotrauma"},{"key":"4016_CR10","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1089\/neu.2019.6551","volume":"37","author":"V Petkus","year":"2020","unstructured":"Petkus V, Preiksaitis A, Chaleckas E et al (2020) Optimal cerebral perfusion pressure: targeted treatment for severe traumatic brain injury. J Neurotrauma 37:389\u2013396","journal-title":"J Neurotrauma"},{"key":"4016_CR11","doi-asserted-by":"publisher","unstructured":"Malinova V, Kranawetter B, Tuzi S, et al: Interaction of Optimal Cerebral Perfusion Pressure with Early Brain Injury and its Impact on Ischemic Complications and Outcome Following Aneurysmal Subarachnoid Hemorrhage [Internet]. Neurocrit Care 2023; [cited 2024 Feb 8] Available from: https:\/\/doi.org\/10.1007\/s12028-023-01822-1","DOI":"10.1007\/s12028-023-01822-1"},{"key":"4016_CR12","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.wneu.2019.01.047","volume":"124","author":"B Foreman","year":"2019","unstructured":"Foreman B, Ngwenya LB (2019) Sustainability of applied intracranial multimodality neuromonitoring after severe brain injury. World Neurosurg 124:378\u2013380","journal-title":"World Neurosurg"},{"key":"4016_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1227\/NEU.0b013e3182191451","volume":"69","author":"HI Chen","year":"2011","unstructured":"Chen HI, Stiefel MF, Oddo M et al (2011) Detection of cerebral compromise with multimodality monitoring in patients with subarachnoid hemorrhage. Neurosurgery 69:53\u201363","journal-title":"Neurosurgery"},{"key":"4016_CR14","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/S0140-6736(22)00938-2","volume":"400","author":"J Claassen","year":"2022","unstructured":"Claassen J, Park S (2022) Spontaneous subarachnoid haemorrhage. Lancet 400:846\u2013862","journal-title":"Lancet"},{"key":"4016_CR15","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3390\/s18020465","volume":"18","author":"M Harary","year":"2018","unstructured":"Harary M, Dolmans RGF, Gormley WB (2018) Intracranial pressure monitoring\u2014review and avenues for development. Sensors 18:465","journal-title":"Sensors"},{"key":"4016_CR16","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3171\/jns.2004.101.3.0408","volume":"101","author":"GG Heuer","year":"2004","unstructured":"Heuer GG, Smith MJ, Elliott JP et al (2004) Relationship between intracranial pressure and other clinical variables in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 101:408\u2013416","journal-title":"J Neurosurg"},{"key":"4016_CR17","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10143-020-01248-9","volume":"44","author":"WA Florez","year":"2020","unstructured":"Florez WA, Garc\u00eda-Ballestas E, Deora H et al (2020) Intracranial hypertension in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Neurosurg Rev 44:203\u2013211","journal-title":"Neurosurg Rev"},{"key":"4016_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3171\/2024.3.JNS232829","volume":"142","author":"NA Picard","year":"2024","unstructured":"Picard NA (2024) The Monro-Kellie doctrine in its own context. J Neurosurg 142:12\u201318","journal-title":"J Neurosurg"},{"key":"4016_CR19","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1007\/s00134-024-07387-7","volume":"50","author":"C Robba","year":"2024","unstructured":"Robba C, Busl KM, Claassen J et al (2024) Contemporary management of aneurysmal subarachnoid haemorrhage. An update for the intensivist. Intensive Care Med 50:646\u2013664","journal-title":"Intensive Care Med"},{"key":"4016_CR20","first-page":"1907","volume":"104","author":"YH Jiang","year":"2024","unstructured":"Jiang YH, Li RT, Lin F et al (2024) Interpretation of Chinese guideline for the clinical management of patients with ruptured intracranial aneurysms (2024). Zhonghua Yi Xue Za Zhi 104:1907\u20131910","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"4016_CR21","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.3390\/antiox11122423","volume":"11","author":"G Hao","year":"2022","unstructured":"Hao G, Eser P, Mo J (2022) Oxidative stress and intracranial hypertension after aneurysmal subarachnoid hemorrhage. Antioxidants 11:2423","journal-title":"Antioxidants"},{"key":"4016_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jocn.2018.04.073","volume":"54","author":"J Cai","year":"2018","unstructured":"Cai J, Fang W, Chen F et al (2018) Cerebral perfusion pressure threshold to prevent delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. J Clin Neurosci 54:29\u201332","journal-title":"J Clin Neurosci"},{"key":"4016_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s12028-016-0240-3","volume":"25","author":"U Johnson","year":"2016","unstructured":"Johnson U, Engquist H, Howells T et al (2016) Bedside xenon-CT shows lower CBF in SAH patients with impaired CBF pressure autoregulation as defined by pressure reactivity index (PRx). Neurocrit Care 25:47\u201355","journal-title":"Neurocrit Care"},{"key":"4016_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/ANA.0b013e318224030a","volume":"24","author":"FA Rasulo","year":"2012","unstructured":"Rasulo FA, Girardini A, Lavinio A et al (2012) Are optimal cerebral perfusion pressure and cerebrovascular autoregulation related to long-term outcome in patients with aneurysmal subarachnoid hemorrhage? J Neurosurg Anesthesiol 24:3\u20138","journal-title":"J Neurosurg Anesthesiol"},{"key":"4016_CR25","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s12028-020-01162-4","volume":"34","author":"T Svedung Wettervik","year":"2021","unstructured":"Svedung Wettervik T, Howells T, Lew\u00e9n A et al (2021) Temporal dynamics of ICP, CPP, PRx, and CPPopt in high-grade aneurysmal subarachnoid hemorrhage and the relation to clinical outcome. Neurocrit Care 34:390\u2013402","journal-title":"Neurocrit Care"},{"key":"4016_CR26","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1097\/CCM.0b013e3182514eb6","volume":"40","author":"MJH Aries","year":"2012","unstructured":"Aries MJH, Czosnyka M, Budohoski KP et al (2012) Continuous determination of optimal cerebral perfusion pressure in traumatic brain injury. Crit Care Med 40:2456\u20132463","journal-title":"Crit Care Med"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-025-04016-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-025-04016-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-025-04016-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:28:35Z","timestamp":1781623715000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-025-04016-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,20]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4016"],"URL":"https:\/\/doi.org\/10.1007\/s10143-025-04016-9","relation":{},"ISSN":["1437-2320"],"issn-type":[{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,20]]},"assertion":[{"value":"3 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical principles of the Declaration of Helsinki. The study was reviewed and approved by the Ethics Committee of the Second Hospital, University of South China (Authorization No.:2024049),and has been registered with the China Clinical Trial Registry (\n                      \n                      . registration number: ChiCTR2500097852).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval declaration"}},{"value":"Written informed consent was obtained from all participants or their legally authorized representatives before participation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate declaration"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"84"}}